Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Clinical trial NCT00247962 · COMPLETED
Trial details
- NCT number
- NCT00247962
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-02-01
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.